Myelofibrosis with myeloid metaplasia (MMM) is an uncommon disorder in young
individuals, for whom haemopoietic stem cell transplantation offers the only possibility of …

The prognostic value of 12 clinical and haematological parameters, recorded at diagnosis,
in myelofibrosis with myeloid metaplasia (MMM) was retrospectively analysed in a …

Between January 1985 and December 1992, 104 consecutive patients with symptomatic
myelofibrosis with myeloid metaplasia (MMM)[splenic enlargement> 5 cm and/or …

The dependence of survival time on a set of prognostic factors was explored by means of
Cox's regression model in 137 cases of myelofibrosis with myeloid metaplasia (MMM). The …

The prognostic significance of bone marrow cytogenetic lesions in myelofibrosis with
myeloid metaplasia (MMM) was investigated in a retrospective series of 165 patients. An …

Among 2333 consecutive patients with myelofibrosis with myeloid metaplasia (MMM) seen
at our institution, 91 fulfilled the World Health Organization (WHO) criteria for leukemic …

PURPOSE: Myelofibrosis with myeloid metaplasia (MMM) is a chronic myeloproliferative
disorder characterized by bone marrow fibrosis and extramedullary hematopoiesis. Recent …

Abstract BACKGROUND Approximately 30–50% of patients with myelofibrosis with myeloid
metaplasia (MMM) demonstrate detectable cytogenetic abnormalities, the prognostic value …

Abstract The European Myelofibrosis Network (EUMNET), a European research network on
myelofibrosis with myeloid metaplasia (MMM), has developed a definition of response for …

Postpolycythemic and postthrombocythemic myeloid metaplasia are consensually referred
to as secondary myelofibrosis (sMF). Prognostic variables in sMF are not as well defined as …